Over the last decade much of the pharmaceutical industry has been beset by the issue of unacceptably low research productivity. In response to this many companies, large and small, are considerably changing the way they interact with the external academic environment. Specifically there is an increasing focus on ensuring that pharmaceutical companies and their scientists are much better connected with the academic research environment and on developing a more extended network of partnerships and genuine collaborations with academia.

This session will thus focus on the rapidly evolving medicinal chemistry interface between industry and academia and on how this is likely to impact on the discipline itself.

The Sunset Session will take place on Monday, September 3, at 18:00.